O'Shaughnessy Asset Management’s Editas Medicine EDIT Stock Holding History

O'Shaughnessy Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,704	Closed	-$152K	–	1586
2021 Q3	$152K	Sell	3,704 -196	-5%	-$10.7K	﹤0.01%	1160
2021 Q2	$221K	Hold	3,900	–	–	﹤0.01%	982
2021 Q1	$164K	Buy	+3,900	New	+$222K	﹤0.01%	1004
2020 Q1	–	Sell	-161	Closed	-$5K	–	1419
2019 Q4	$5K	Buy	+161	New	+$4.02K	﹤0.01%	1445

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

O'Shaughnessy Asset Management's EDIT Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 3,704 shares — an estimated $152K sold.

O'Shaughnessy Asset Management first reported a position in EDIT in Q4 2019 and held it in 4 quarters. The position peaked at $221K in Q2 2021. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 3,704 Editas Medicine shares in Q4 2021, an estimated $152K.
O'Shaughnessy Asset Management first reported a position in Editas Medicine in Q4 2019 and held it in 4 quarters.
O'Shaughnessy Asset Management's Editas Medicine position peaked at $221K in Q2 2021.
305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.